Depot Disulfiram for AIDS and ARC
Study Details
Study Description
Brief Summary
To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
N/A |
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria
Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria.
-
Also patient must be:
-
Able to understand the study.
-
Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms.
-
Ambulatory and able to maintain an independent life outside the hospital.
-
Free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
History of alcohol abuse.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Saint Vincent's Med Ctr | Staten Island | New York | United States | 10310 |
Sponsors and Collaborators
- St. Vincent's Medical Center
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 024A